1,512
Participants
Start Date
January 8, 2023
Primary Completion Date
April 29, 2023
Study Completion Date
December 31, 2024
Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine
0.5 mL of vaccine containing a total of 60 µg of protein (20 µg of each P type) adjuvanted with 0.5 mg aluminum hydroxide.
High dose Recombinant Trivalent Subunit Rotavirus Vaccine
0.5 mL of vaccine containing a total of 90 µg of protein (30 µg of each P type) adjuvanted with 0.5 mg aluminum hydroxide.
Placebo
0.5 mL per dose, containing 0.5 mg aluminium hydroxide adjuvant.
Shangqiu Liangyuan District Center for Disease Control and Prevention, Shangqiu
Ningling County Center for Disease Control and Prevention, Shangqiu
Lead Sponsor
Henan Center for Disease Control and Prevention
OTHER_GOV
MAXVAX Biotechnology Limited Liability Company
INDUSTRY